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Background: The histopathological subtype, nuclear grade and presence or absence of comedonecrosis are
established as critical elements in the reporting of ductal carcinoma in situ (DCIS) of the breast. The aims of this
study were to determine the frequencies of morphological subtypes of DCIS, nuclear grade and comedonecrosis;
to compare the age of patients with the histopathological characteristics of DCIS, and to assess the agreement of
grade between in situ and invasive components in DCIS cases that were associated with invasive carcinoma.
Methods: We evaluated a series of 403 cases of DCIS, pure or associated with invasive mammary carcinoma,
consecutively identified from the histopathology files of the Breast Pathology Laboratory, Federal University of
Minas Gerais, Brazil, from 2003 to 2008.
Results: DCIS displayed a single growth pattern in most cases (55.1%) and the solid subtype was the most common
morphology (42.2% of the total). High-grade DCIS was identified in 293/403 cases (72.7%) and comedonecrosis was
present in 222/403 cases (55%). Among DCIS with a single architectural pattern, high grade was more common in the
solid subtype (151/168 cases, 89.9%; p < 0.001). Only 32% of tumours with a cribriform pattern had high nuclear grade.
Comedonecrosis was more common in the solid morphology than in the cribriform, papillary and micropapillary
subtypes (p < 0.001). Patients with high-grade DCIS were younger in relation to patients with low-grade DCIS
(p = 0.027) and patients with tumours with comedonecrosis were also younger in comparison to patients with tumours
without comedonecrosis (p = 0.003). Fair agreement was observed between in situ and invasive components with regard
to grade (weighted kappa = 0.23).
Conclusions: The high nuclear grade and the presence of comedonecrosis were identified more frequently in younger
patients and more often correlated with the solid pattern of DCIS.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
13000_2014_227
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Ductal carcinoma in situ of the breast (DCIS) is defined
as a neoplastic proliferation of epithelial cells confined
to the mammary ductal-lobular system and character-
ized by subtle to marked cytological atypia and an inher-
ent but not necessarily obligate tendency for progression
to invasive breast cancer [1]. DCIS constitutes 20% of all
newly diagnosed breast cancer cases and 30% to 40% of* Correspondence: hgobbi@medicina.ufmg.br
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unless otherwise stated.the breast cancer cases diagnosed mammographically in
the United States of America [2,3].
Currently, it is accepted that DCIS is not one entity
but rather a heterogeneous group of lesions with differ-
ent clinical, radiological, morphological and genetic fea-
tures [4,5].
Genetic and molecular studies have been published aim-
ing to establish prognostic and predictive factors and new
targeted therapies to reduce the risk of recurrence and
progression to invasive carcinoma in patients with DCIS
[2,6-12]. These advances may become an important parttd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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necrosis and margin status are established as critical ele-
ments in the reporting of DCIS [1,13].
The purpose of this study was to determine the fre-
quencies of DCIS subtypes, nuclear grade and comedo-
necrosis of a series of cases of DCIS of the breast; to
compare the age of patients with the histopathological
characteristics of DCIS, and to assess the agreement of
grade between in situ and invasive components in DCIS
cases that were associated with invasive carcinoma.Methods
Four hundred and three cases of DCIS, pure or associated
with invasive carcinoma, were consecutively identified
from the histopathology files of the Breast Pathology
Laboratory, School of Medicine, Federal University of
Minas Gerais, Brazil, from 2003 to 2008. Histopathological
sections from all cases were reviewed by two authors
(HG and AAP) and data considered in the analysis was
that obtained in the current slide review.
The criteria defined by World Health Organization
(2012) were used for histopathological diagnosis, classifi-
cation and grading of DCIS and invasive carcinoma [1].
The nuclear grade of DCIS was classified as low, inter-
mediate or high on the basis of nuclear size, pleomorph-
ism, chromatin pattern, presence of nucleoli and mitotic
activity. DCIS with low nuclear grade consists of a mon-
otonous population of cells with slightly enlarged nuclei,
smooth nuclear membranes, finely dispersed chromatin,
inconspicuous nucleoli and rare mitoses. The cells of
low-grade DCIS are typically polarized with the longest
axis of the cell oriented perpendicularly to the basement
membrane, and radially distributed around neoformed
extracellular lumina. DCIS of intermediate nuclear grade
consists of a population of cells with intermediate-size
nuclei with coarser chromatin and evident but still in-
conspicuous nucleoli. Mitotic activity may be encoun-
tered, but it is rarely high. The neoplastic cells may be
polarized. DCIS of high nuclear grade consists of cells
with large (>2.5 times the size of a red blood cell) and
pleomorphic nuclei that show vesicular and coarse chro-
matin, with prominent and often multiple and irregular
nucleoli. The neoplastic epithelial cells usually lack po-
larity, and mitotic activity is easily detected [1,14]. The
highest nuclear grade was used for the purpose of statis-
tical analysis. The nuclear grade of DCIS was not evalu-
ated in eleven cases (2.7%) because the slides were not
available for review. The grade of invasive carcinoma
was classified as low, intermediate or high based on an
assessment of tubule/gland formation, nuclear pleo-
morphism and mitotic count [1]. Tubular formation was
assessed over the whole tumour; nuclear pleomorphism
was evaluated in the area showing the highest degree ofpleomorphism, and mitotic counting was performed in
the area exhibiting most proliferation [1].
The architectural patterns of DCIS included solid,
cribriform, micropapillary, papillary and apocrine [1].
DCIS was divided into single (when >90% of the in situ
tumor displayed one architectural growth pattern) and
mixed (when the dominant pattern constituted <90% of
the in situ carcinoma) [15].
The term comedonecrosis, which is poorly defined in
the literature, was applied when significant necrosis, cre-
ating an appearance similar to comedos, seen in cutane-
ous acne, was noted in ducts involved by DCIS [15,16].
We measured the largest focus of all pure DCIS cases.
Because not all slides from each case were available to
be reviewed, we did not analyze margin status and size
of DCIS in cases associated with invasive carcinoma.
Pearson’s asymptotic test was used to compare propor-
tions. The t test was used to compare age means among
the groups and the Bonferroni test was used to multiple
comparisons between them. The weighted kappa test was
used to assess the concordance between nuclear grade of
DCIS and histological grade of invasive carcinoma. Kappa
values in the range 0.21 to 0.40 demonstrated fair agree-
ment [17]. A p value <0.05 was considered statistically
significant. This study was approved by the Research
Ethics Committee of the Federal University of Minas
Gerais (protocol ETIC 655/08).
Results
Pure DCIS was detected in 110/403 cases (27.3% of the
total) and 293/403 cases (72.7% of the total) were DCIS
associated with invasive carcinoma.
The mean age of patients at diagnosis was 54.1 years
(standard deviation ± 13.1). There was no significant dif-
ference in age between pure DCIS and DCIS associated
with invasive carcinoma (p = 0.814).
The mean size of pure DCIS was 15.2 mm (range: 2 to
100 mm; standard deviation ± 15.8). There was no sig-
nificant difference between the size of pure DCIS and
age (p = 0.938), neither between the size of pure DCIS
and presence of comedonecrosis (p = 0.732). We did not
find a significant difference in size between single
growth pattern and mixed growth pattern (p = 0.213),
and also between the size and the nuclear grade (p =
0.175). There was no significant difference between the
size and the subtype of DCIS (p = 0.137). However, we
identified a tendency of the micropapillary subtype to be
larger than the other subtypes (p = 0.06).
The frequencies of DCIS subtypes are shown in
Table 1. Of the 403 cases of DCIS (pure and associated
with invasive carcinoma), 222 cases (55.1%) displayed a sin-
gle growth pattern and 181 cases (44.9%) showed a mixed
growth pattern. Among architectural patterns, the solid
subtype was the most common (170/403 cases; 42.2%). The
Table 1 Frequencies of ductal carcinoma in situ subtypes









Table 2 Frequencies of nuclear grade of ductal carcinoma
in situ
Nuclear grade N %
Low grade 38 9.4
Intermediate grade 61 15.2
High grade 293 72.7
Missing 11 2.7
Total 403 100
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(3.2%). The apocrine morphology was not identified among
DCIS with a single architectural pattern. There was no
significant difference in single or mixed growth pattern be-
tween pure DCIS and DCIS associated with invasive carcin-
oma (p = 0.088).
The nuclear grade of DCIS was evaluated in 392/403
cases (97.3%; Fig. 1A-C). High-grade DCIS was identified in
293/403 cases (72.7%; Figure 1C). There was no significant
difference in nuclear grade between pure DCIS and DCIS
associated with invasive carcinoma (p = 0.142). The fre-
quencies of different nuclear grades of DCIS and the rela-
tionship between nuclear grade and different single
architectural patterns are respectively shown in Tables 2Figure 1 Ductal carcinoma in situ of the breast: different nuclear grad
cribriform type, showing uniform cells with mild atypia. Hematoxylin and e
cells with mild a moderate atypia and focal necrosis. Hematoxylin and eosi
severe atypical cells, without necrosis. Hematoxylin and eosin, x400. D – High
Hematoxylin and eosin, x200.and 3. Among DCIS with a single architectural pattern,
high grade was more common in the solid subtype (151/
168 cases, 89.9%; p < 0.001). Only 32% of tumors with a
cribriform pattern had high nuclear grade.
Comedonecrosis was present in 222/403 cases (55%;
Figure 1D). The frequencies of comedonecrosis in differ-
ent architectural patterns are shown in Table 4. Among
DCIS cases with a single growth pattern, comedonecro-
sis was more often in cases with a solid morphology
(p < 0.001). The cribriform, papillary and micropapillary
subtypes more frequently did not present comedonecro-
sis (p < 0.001).
Patients with high-grade DCIS were younger (mean
age = 53 years) in relation to patients with low-grade
DCIS (mean age = 58.4 years; p = 0.027). Patients with
tumours with comedonecrosis were also younger ines and comedonecrosis. A - Low grade ductal carcinoma in situ,
osin, x200. B – Intermediate grade ductal carcinoma in situ, showing
n, x200. C – High grade ductal carcinoma in situ, solid type, showing
grade ductal carcinoma in situ, solid type with extensive comedonecrosis.
Table 3 Nuclear grade and architectural patterns of ductal carcinoma in situ
Architectural Pattern*
Nuclear grade Solid N (%) Cribriform N (%) Papillary N (%) Micropapillary N (%) Total
Low 08 (4.8) 08 (32.0) 02 (16.7) 02 (16.7) 20 (9.2)
Intermediate 09 (5.3) 09 (36.0) 01 (8.3) 01 (8.3) 20 (9.2)
High 151 (89.9) 08 (32.0) 09 (75.0) 09 (75.0) 177 (81.6)
Total 168 (100) 25 (100) 12 (100) 12 (100) 217 (100)
Missing 02 02 00 01 p < 0.001
*Single growth pattern; p = significance level.
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necrosis (p = 0.003).
Invasive carcinoma of no special type was the most
common (262/293 cases; 88.7%), followed by the tubular
carcinoma (12/293 cases; 4.1%), mucinous carcinoma
(07/293 cases; 2.4%), invasive lobular carcinoma (04/293
cases; 1.4%), invasive papillary and micropapillary carcin-
omas (03/293 cases each one; 1%), secretory and cribri-
form carcinomas (02/293 cases each one; 0.7%).
Fair agreement was observed between in situ and
invasive components with regard to grade (weighted
kappa = 0.23).
Discussion
In the present study we evaluated morphological fea-
tures of a series of DCIS pure (110 cases, 27.3% of the
total) or associated with an invasive component (293
cases, 72.7% of the total) correlating them with the age
of patients. Clinical and histological characteristics that
may predict the risk of recurrence in women with DCIS
include the age, tumour grade, presence of comedone-
crosis, architectural subtype, tumour size, and width of
resection margin [18,19]. In our series we evaluated nu-
clear grade, tumour size, comedonecrosis and age that
are well established critical elements in the reporting of
DCIS. Although recent genetic, molecular and immuno-
histochemical studies have contributed to advances in
the understanding of the pathogenesis of DCIS, age and
histopathological features remain the most established
predictors of behavior in DCIS [1,8,20-26].
In our series, the majority of the cases (293 cases,
72.7% of the total) were high-grade DCIS; 15.2% of cases
had an intermediate grade and 9.4% were low-grade
CDIS. The classification of DCIS has been based on theTable 4 Comedonecrosis and architectural patterns of ductal
Architectural
Comedonecrosis Solid N (%) Cribriform N (%) P
Absent 36 (21.2) 21 (77.8) 0
Present 134 (78.8) 06 (22.2) 0
Total 170 (100) 27 (100) 1
*Single growth pattern; p = significance level.architectural growth pattern. Cytonuclear differentiation
of tumour cells is more important than the architectural
growth pattern and various novel classifications of DCIS
have been proposed. Almost all modern classifications
separate DCIS into three categories (high, intermediate,
and low grade), but differ in the choice of features that
are used for categorization [27]. Studies have reported
nuclear grade to be the most significant predictor of re-
currence on both univariate and multivariate analysis
[28,29]. Therefore, cytonuclear grade has been used as
the basic method for the assessment of intrinsic bio-
logical aggressiveness. Scripcaru and colleagues recog-
nized, respectively, high-grade DCIS and intermediate
nuclear grade in 45% and 41% of their cases [15]. These
differences in the frequencies of grade are possibly at-
tributed to the variation in the classification criteria, to
the differences between the populations or to the detec-
tion method of the tumours (clinical or mammographi-
cally detected tumours).
We also correlated the nuclear grade of DCIS with the
histological grade of invasive carcinoma to assess the
agreement between in situ and invasive components in
DCIS cases that were associated with invasive carcin-
oma. The fair agreement between in situ and invasive
components with regard to grade (weighted kappa =
0.23) observed in our study is probably related to the
various categories (grades 1, 2 or 3) included in the stat-
istical analysis.
We showed that comedonecrosis was significantly
more often in solid morphology than in cribriform, papil-
lary and micropapillary subtype (p < 0.001). Scripcaru
et al. also identified a statistically significant difference be-
tween the presence of comedonecrosis in micropapillary
and solid subtypes versus the cribriform morphology [15].carcinoma in situ
Pattern*
apillary N (%) Micropapillary N (%) Total
9 (75.0) 08 (61.5) 74 (33.3)
3 (25.0) 05 (38.5) 148 (66.7)
2 (100) 13 (100) 222 (100)p < 0.001
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architectural pattern. The term “comedo DCIS” is widely
used in historical series but does not confer either a spe-
cific grade or architecture to the lesion and there is no
consensus in the literature regarding the amount of cen-
tral necrosis required, so reproducibility as a category of
DCIS is questionable [4]. Although rates of ipsilateral
breast tumour recurrence are generally higher for tumours
with a component of comedonecrosis than for those with-
out, irrespective of adjuvant therapies, the presence of ne-
crosis might be a weaker predictor of ipsilateral breast
tumor recurrence than cellular architecture and nuclear
grade [30].
The architectural patterns of DCIS include solid, crib-
riform, micropapillary, papillary and unusual variants
(apocrine, signet ring, neuroendocrine, spindled, squa-
mous or clear cells) [1]. Some combinations of nuclear
grade and architectural pattern tend to be more frequent
than others but any combination can occur [7]. The
current World Health Organization classification does
not recognize the low-grade (monomorphic) variant of
DCIS with an exclusive flat type (clinging) pattern and
did not recommend this terminology [1].
Our results showed that high grade was more com-
mon in the solid subtype (89.9%; p < 0.001) and only
32% of tumors with a cribriform pattern had high nu-
clear grade. Solid DCIS is characterized by a prolifera-
tion of neoplastic cells that fill, expand, and distort a
duct. Nuclear grades can range from high to low in solid
DCIS, although pure solid DCIS with low nuclear grade
is fairly rare. Low-grade DCIS with solid architecture
sometimes raises the differential diagnosis of lobular
carcinoma in situ [1,31-33]. Cribriform DCIS is charac-
terized by well-defined lumens lined by neoplastic
cells. Such an orderly arrangement is rare in high-
grade DCIS [7].
DCIS most frequently (62%) shows a mixture of
architectures, which is seen almost twice as often as the
second most commonly seen pattern (solid, 31.9%) [4].
In our series, 55.1% of cases displayed a single growth
pattern and 44.9% showed a mixed growth pattern.
Among architectural patterns, the solid subtype was
more common (42.2%). Similar to our results, Scripcaru
and colleagues also described that 58% of cases of DCIS
displayed a single growth pattern and 42% showed a
mixed growth pattern [15].
Silverstein’s group showed age to be an independent
prognostic factor for local recurrence, which led to in-
corporation of age into the Van Nuys Prognostic Index
by the division of patients into three groups (≥ 61 years,
40–60 years and ≤ 39 years) [34]. Goldstein et al. exam-
ined pathologic features of DCIS in three different age
groups of patients to identify differences that might ex-
plain why young patient age at the time of diagnosis is arisk for recurrence. They found that younger patients
more frequently had higher nuclear grade DCIS, central
necrosis, smaller initial biopsy maximum dimensions
and close or positive margins [35].
In our series, patients with high grade DCIS were youn-
ger in relation to patients with low grade DCIS (p = 0.027)
and patients with tumours with comedonecrosis were also
younger in comparison to patients with tumours without
comedonecrosis (p = 0.003). This group of younger pa-
tients may have an increased risk of local recurrence when
treated with breast-conserving therapy due to a greater
proportion of high nuclear grade DCIS and presence of
comedonecrosis. In the present study, the type of treat-
ment (radical or breast-conserving therapy) and the local
recurrence were not evaluated. Maybe the association of
high nuclear grade DCIS, comedonecrosis and younger
patients can guide the clinicians to perform more aggres-
sive surgical treatments, as these factors are associated
with local recurrence.Conclusions
The high nuclear grade and the presence of comedone-
crosis were identified more frequently in DCIS of youn-
ger patients and more often correlated with the solid
pattern DCIS. As clinical and histopathological features
remain the most established predicts of behavior in
DCIS, the choice of surgical treatment should be guide
by them in addition to the size of DCIS and margin
status.Consent
Written informed consent was obtained from the pa-
tients for the publication of this report and any accom-
panying images.
Abbreviation
DCIS: Ductal carcinoma in situ.
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